Navigation Links
Advancements in Population Age and Technology Drive Future of Orthopedic Materials Market
Date:9/26/2007

NEW YORK, Sept. 26 /PRNewswire/ -- The world orthopedic biomaterials market, valued at $4 billion in 2006, is projected to accelerate in tandem with the world's aging population, reaching $8.8 billion in 2012, according to Orthopedic Biomaterials: World Market, a new report by Kalorama Information.

Changing demographics -- particularly a world population that is expected to include 2 billion individuals aged 60 or older by 2050, improved longevity, and higher quality-of-life expectations -- are driving the number of musculoskeletal conditions being diagnosed and treated across the globe. In Europe, 15-20% of all primary care consultations are for musculoskeletal conditions. In the United States, one out of every seven Americans reports a musculoskeletal impairment.

BMP (bone morphogenetic proteins) products, the newest and fastest growing segment in the orthopedic biomaterials market, are expected to increase their sales and holdings in the market during the forecasted period, growing by a CAGR of 25% to $2.9 billion and accounting for 39% of the market. Ceramic product sales, which accounted for 25% of the market in 2006, are projected to grow at a steady CAGR of 10% between 2006-2012 but account for only 21% of the orthopedic materials market by 2012.

"As a result of evolving technology, a number of biomaterials have been introduced to the market over the past several years, all of which are biologically active substances intended to extend, enhance, or even replace autologous graft," notes Anne Anscomb, the report's author. "However, it is the most recent innovations in the orthopedic biomaterials, the development of recombinant bone morphogenetic proteins (BMPs) and synthetic ceramic products, which show the greatest promise in the quest for the perfect orthopedic biomaterial."

Orthopedic Biomaterials: World Market focuses on products and markets for bone allografts and bone graft substitutes, which include allograft bone substitut
'/>"/>

SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Liability issues not seen as roadblock to healthcare technology advancements
2. Governor Doyle Pledges Support for Stem Cell Research and Biotechnology Advancements
3. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
4. Using the DCode System to Identify DNA Sequence Variation for Studies of Population Structure in Marine Organisms
5. Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays
6. Laser Capture Microdissection of muscle fiber populations and expression analysis by RT-PCR
7. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
8. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
9. Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep Technology
10. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
11. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... patent-protected processes to develop and market advanced products and ... Medicine, Ophthalmic and Dental sectors of healthcare, announced today ... Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)...  Merck KGaA, Darmstadt, Germany , ... in the healthcare, life science and performance materials sectors, ... development and launch of promising new fullerene derivatives for ... Darmstadt, Germany , is pursuing many ... Novel derivatives: highly stable, easy to process and ...
(Date:8/3/2015)... , Aug. 3, 2015  Aethlon Medical, Inc. (Nasdaq: ... to treat life-threatening diseases, today announced that it will ... and webcast on Thursday, August 13, 2015 at 4:30 ... will follow the release of fiscal 2016 first quarter ... available approximately two hours after the call at the ...
(Date:8/3/2015)... Md. , Aug. 3, 2015   Intrexon ... will release first half and second quarter 2015 financial ... th , 2015.  The Company will host a conference ... and provide a general business update. The ... US) and 1-412-902-4262 (International), and asking to join the ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2
... today announced that Garry W. Rogerson, President and CEO,will speak ... Thursday,December 4, 2008 at 9:45 a.m. Eastern time. , ... presentation will be publicly available from Varian,Inc.,s Web site at ... on "Investors." An archived replay will be available to ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA) will host ... its drug development programs and financial results,for the third ... Kuo,MD, MBA, will host the call and there will ... To participate in the teleconference, please ...
... Nov. 20 Cyntellect, a privately-held life,sciences company ... manipulation and purification systems, announced today that it ... University of Florida ,Interdisciplinary Center for Biotechnology Research. ... research areas including the purification and analysis of,cancer ...
Cached Biology Technology:Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 2Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 3Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 4Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 5Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 6Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 7University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells 2University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells 3
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the fourth ... 2015 after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 /PRNewswire/ ... today announced BD & Guidepoint Mentor, a ... access to Guidepoint,s expert network services. ... cutting-edge technologies to improve healthcare delivery and outcomes and, ... each start-up entrepreneur will be able to directly engage ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... a revised version of one of its first 30 second commercials ... in New York , Chicago ... Francisco metro areas.    , , , ... all the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... at the heart of a novel agricultural technique to manage ... can be used to turn carbon dioxide emissions into soil-enriching ... thrives in tropical areas, such as West Africa. ... in dry, acidic soil and treated with a combination of ...
... Researchers at the Instituto Andaluz de Ciencias de la Tierra ... was recently published in the prestigious journal Reviews of ... from 11 different countries has published the most comprehensive study ... the most important contemporary issues in a field of research ...
... Endocrine Society,s Journal of Clinical Endocrinology and Metabolism ... reduce the rate of mortality in seniors, therefore providing ... During the last decade, there has been increasing ... It is well known that calcium with vitamin D ...
Cached Biology News:Bugs have key role in farming approach to storing CO2 emissions 2Spanish scientist participate in the most comprehensive study ever done on ice 2
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
Rab1A...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Biology Products: